Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis.
Colin O'RourkeAlyssa YlescupidezHenry T BahnsonChristine BenderCate SpeakeSandra LordCarla J GreenbaumPublished in: The Journal of clinical endocrinology and metabolism (2022)
Our study has clinical implications for metabolic monitoring of at-risk individuals. Fewer monitoring visits would reduce clinical burden, suggesting a path toward transitioning monitoring beyond the research setting.
Keyphrases